trending Market Intelligence /marketintelligence/en/news-insights/trending/VqB_Vuh7Xl6XDN7bkaCPRw2 content esgSubNav
In This List

Iovance Biotherapeutics names CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Iovance Biotherapeutics names CFO

Iovance Biotherapeutics Inc. appointed Timothy Morris to be CFO, effective Aug. 14.

Morris most recently served as CFO and head of business development of AcelRx Pharmaceuticals Inc.